statistiche ricercatore

MANCINI, NICASIO

Distribuzione geografica

Continente	#
NA - Nord America	8.690
EU - Europa	4.513
AS - Asia	4.138
Continente sconosciuto - Info sul continente non disponibili	504
SA - Sud America	469
AF - Africa	101
OC - Oceania	14
Totale	18.429

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	8.366
IT - Italia	2.787
SG - Singapore	1.783
CN - Cina	866
HK - Hong Kong	606
BR - Brasile	390
VN - Vietnam	375
GB - Regno Unito	317
FR - Francia	257
DE - Germania	214
RU - Federazione Russa	180
CA - Canada	176
FI - Finlandia	165
IE - Irlanda	156
IN - India	111
SE - Svezia	103
BD - Bangladesh	98
UA - Ucraina	91
MX - Messico	83
TR - Turchia	80
JP - Giappone	51
PL - Polonia	43
AT - Austria	40
NL - Olanda	39
ES - Italia	31
IQ - Iraq	28
ZA - Sudafrica	27
AR - Argentina	26
LT - Lituania	26
NG - Nigeria	23
SA - Arabia Saudita	22
BE - Belgio	19
AE - Emirati Arabi Uniti	13
CO - Colombia	12
CR - Costa Rica	12
KE - Kenya	12
PK - Pakistan	12
TT - Trinidad e Tobago	12
AU - Australia	11
CH - Svizzera	11
ID - Indonesia	11
MY - Malesia	11
VE - Venezuela	11
EC - Ecuador	10
MA - Marocco	9
UZ - Uzbekistan	9
JM - Giamaica	8
JO - Giordania	8
CL - Cile	7
PH - Filippine	7
AZ - Azerbaigian	6
ET - Etiopia	6
PE - Perù	6
PR - Porto Rico	6
TN - Tunisia	6
BB - Barbados	5
EG - Egitto	5
IL - Israele	5
MD - Moldavia	5
NI - Nicaragua	5
GR - Grecia	4
GT - Guatemala	4
HN - Honduras	4
KR - Corea	4
LB - Libano	4
BG - Bulgaria	3
BH - Bahrain	3
CI - Costa d'Avorio	3
EE - Estonia	3
KZ - Kazakistan	3
NO - Norvegia	3
QA - Qatar	3
SC - Seychelles	3
SV - El Salvador	3
UY - Uruguay	3
BY - Bielorussia	2
CZ - Repubblica Ceca	2
DK - Danimarca	2
EU - Europa	2
GE - Georgia	2
IR - Iran	2
KH - Cambogia	2
NP - Nepal	2
PA - Panama	2
PY - Paraguay	2
RS - Serbia	2
RW - Ruanda	2
SI - Slovenia	2
TH - Thailandia	2
VC - Saint Vincent e Grenadine	2
AF - Afghanistan, Repubblica islamica di	1
AL - Albania	1
AM - Armenia	1
AO - Angola	1
BN - Brunei Darussalam	1
BO - Bolivia	1
BS - Bahamas	1
BZ - Belize	1
CG - Congo	1
CW - ???statistics.table.value.countryCode.CW???	1
Totale	17.910

Salva come PNG Salva come JPEG

Città	#
Milan	1.460
San Jose	1.417
Singapore	947
Ashburn	878
Council Bluffs	860
Hong Kong	595
Dallas	491
Chicago	448
Beijing	307
The Dalles	243
Boardman	225
Los Angeles	195
Lauterbourg	179
London	177
Rome	160
Dublin	151
Fairfield	141
Santa Clara	137
New York	121
Ho Chi Minh City	111
Naples	111
Helsinki	107
Varese	107
Chandler	94
Hanoi	86
Seattle	82
Jacksonville	74
Munich	71
Houston	64
Como	60
Salt Lake City	59
Brooklyn	57
Catania	55
Woodbridge	55
Toronto	53
Wilmington	53
Frankfurt am Main	52
Mexico City	51
Ogden	49
Washington	47
Atlanta	46
Chennai	45
Tokyo	44
Ann Arbor	41
Orem	41
São Paulo	39
Warsaw	37
Montreal	35
Nyköping	35
San Francisco	33
Cambridge	32
Phoenix	32
Tampa	32
Guangzhou	31
Princeton	31
Denver	30
Vienna	29
Nuremberg	27
Izmir	26
Magnago	26
Boston	24
Buffalo	24
Elk Grove Village	24
Lancaster	24
Abuja	23
Dearborn	23
Shanghai	23
Da Nang	22
Johannesburg	21
San Diego	21
Amsterdam	19
Shenzhen	18
Brussels	17
Vancouver	17
Dhaka	16
Haiphong	16
West Jordan	16
Memphis	15
North Bergen	15
Rio de Janeiro	15
Stockholm	14
Ankara	13
Belo Horizonte	13
Charlotte	13
Lappeenranta	13
Manchester	13
Mumbai	13
Poplar	13
Verona	13
Assago	12
Nairobi	12
New Delhi	12
Newark	12
Pune	12
Turku	12
Miami	11
Milwaukee	11
Pittsburgh	11
San José	11
Sterling	11
Totale	11.960

Salva come PNG Salva come JPEG

Nome	#
A diet enriched in omega-3 PUFA and inulin prevents type 1 diabetes by restoring gut barrier integrity and immune homeostasis in NOD mice	547
Characterization of a lineage C.36 SARS-CoV-2 isolate with reduced susceptibility to neutralization circulating in Lombardy, Italy	489
Identification of novel molecules supporting the impact of β-lactams against clinically-relevant Gram-negative multidrug resistant organisms	206
Antigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques.	202
Coronaviridae and SARS-associated coronavirus strain HSR1.	201
A modified Frosch approach for posterior tibial plateau fractures: technical note and case series	200
Global spread of Streptococcus pyogenes A genomics-supported narrative review	197
Multicenter Cross-sectional Study on the Epidemiology of Human Metapneumovirus in Italy, 2022–2024, With a Focus on Adults Over 50 Years of Age	188
Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site.	188
Cross-reactive pseudovirus-neutralizing anti-envelope antibodies coexist with antibodies devoid of such activity in persistent hepatitis C virus infection.	186
Monoclonal antibodies isolated from human B cells neutralize a broad range of H1 subtype influenza A viruses including swine-origin Influenza virus (S-OIV).	179
Circulating SARS-CoV-2 variants in Italy, October 2020-March 2021	172
Cloning and molecular characterization of a human recombinant IgG Fab binding to the Tat protein of human immunodeficiency virus type 1 (HIV-1) derived from the repertoire of a seronegative patient.	171
Quantitation of Bacillus clausii in biological samples by real-time polymerase chain reaction.	169
A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments.	149
SARS-CoV-2 detection in primary thyroid sarcoma: coincidence or interaction?	149
A spatial multi-scale fluorescence microscopy toolbox discloses entry checkpoints of SARS-CoV-2 variants in Vero E6 cells	146
A biologically-validated HCV E1E2 heterodimer structural model	136
ACOD1 deficiency offers protection in a mouse model of diet-induced obesity by maintaining a healthy gut microbiota	134
In Vitro Antimicrobial Activity of the Siderophore Cephalosporin Cefiderocol against Acinetobacter baumannii Strains Recovered from Clinical Samples	131
Heterogeneity of the humoral anti-HCV/E2 response in persistently infected patients as demonstrated by divergent patterns of inhibition of the binding of anti-HCV/E2 human monoclonal antibodies.	131
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19	128
A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes	126
Phage display for the production of human monoclonal antibodies against human pathogens.	126
Analysis of the faecal microbiome during analytical treatment interruption in people with chronic HIV infection and long-lasting virological suppression (APACHE study)	121
Type III interferons disrupt the lung epithelial barrier upon viral recognition	120
Molecular cloning of the first human monoclonal antibodies neutralizing with high potency swine-origin influenza A pandemic virus (S-OIV).	120
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases	118
Identification of novel molecules supporting the impact of β-lactams against clinically-relevant Gram-negative multidrug resistant organisms	118
Humoral immune response against hepatitis C virus.	118
Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies	117
Nanopore ReCappable sequencing maps SARS-CoV-2 5' capping sites and provides new insights into the structure of sgRNAs	117
Epidemiological impact of human adenovirus as causative agent of respiratory infections: An Italian multicentre retrospective study, 2022–2023	113
Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening	113
The IN SIGNO project: Identification of novel molecules supporting the impact of β-lactams against clinically-relevant Gram-negative multidrug resistant organisms	112
Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patients	111
Clinical characterization and whole genome sequence-based typing of two cases of endophthalmitis due to Listeria monocytogenes	110
Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies	110
Broadly neutralizing anti-influenza human monoclonal antibodies and their possible role in predictive medicine	109
A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses	109
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein	109
Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2	108
IFCC interim guidelines on rapid point-of-care antigen testing for SARS-CoV-2 detection in asymptomatic and symptomatic individuals	108
Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections	107
Genomic Epidemiology of the Main SARS-CoV-2 Variants Circulating in Italy During the Omicron Era	107
Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools	106
A case of psoriatic arthritis triggered by SARS-CoV-2 infection	106
Epidemiological characteristics of non-polio enteroviruses in respiratory infections: An Italian multicentre retrospective study, 2022–2023	105
Sex-specific Alterations in the Urinary and Tissue Microbiome in Therapy-naïve Urothelial Bladder Cancer Patients	105
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models	104
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes	102
Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine	102
Maturation signatures of conventional dendritic cell subtypes in COVID‐19 suggest direct viral sensing	101
A human stem cell-derived neurosensory–epithelial circuitry on a chip to model herpes simplex virus reactivation	99
Microbiome studies in the medical sciences and the need for closer multidisciplinary interplay	98
JN.1 variants circulating in Italy from October 2023 to April 2024: genetic diversity and immune recognition	98
Acute respiratory distress in a neutropenic febrile patient after hematopoietic cell transplantation	98
Combined Use of Phenotypic Screening and of a Novel Commercial Assay (REALQUALITY Carba-Screen) for the Rapid Molecular Detection of Carbapenemases: A Single-Center Experience	98
Possible future monoclonal antibody (mAb)-based therapy against arbovirus infections	98
The efficacy of ultraviolet light-emitting technology against coronaviruses: a systematic review	97
Autoimmune hepatitis and occult HCV infection: A prospective single-centre clinical study	97
An outbreak caused by multidrug-resistant OXA-58-positive Acinetobacter baumannii in an intensive care unit in Italy	96
Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogens	96
Identification of a novel mutation involved in colistin resistance in Klebsiella pneumoniae through Next-Generation Sequencing (NGS) based approaches	96
Answer to photo quiz: Streptococcus pneumoniae	95
Global and local envelope protein dynamics of hepatitis C virus determine broad antibody sensitivity	95
Differential composition of vaginal microbiome, but not of seminal microbiome, is associated with successful intrauterine insemination in couples with idiopathic infertility: A prospective observational study	94
The interferon landscape along the respiratory tract impacts the severity of COVID-19	94
Anti-hepatitis C virus E2 (HCV/E2) glycoprotein monoclonal antibodies and neutralization interference	93
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion?	92
Levofloxacin prophylaxis vs no prophylaxis in neutropenic patients within an endemic country for carbapenem-resistant GNB	92
JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes?	92
Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19	92
A closer look at prion strains: characterization and important implications	89
Molecular characterization of emerging Echovirus 11 (E11) shed light on the recombinant origin of a variant associated with severe hepatitis in neonates	89
Early molecular diagnosis of aspergillosis in a patient with acute myeloid leukaemia	89
Combined prophylactic and therapeutic use maximizes hydroxychloroquine anti-SARS-CoV-2 effects in vitro	89
Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols	89
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects	89
Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials	86
Lower nasopharyngeal viral load during the latest phase of COVID-19 pandemic in a Northern Italy University Hospital	86
Molecular characterization of the human neutralizing response against hepatitis C virus and its role in the prediction of the infection outcome	86
Viral respiratory pathogens and lung Injury	85
Torquetenovirus Viremia Quantification Using Real-Time PCR Developed on a Fully Automated, Random-Access Platform	84
IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19	84
Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020	84
IFCC interim guidelines on molecular testing of SARS-CoV-2 infection	83
Heterosubtypic protection conferred by the human monoclonal antibody PN-SIA28 against influenza A virus lethal infections in mice	82
Microbiome markers are early predictors of acute GvHD in allogeneic hematopoietic stem cell transplant recipients	82
Molecular signatures of hepatitis C virus (HCV)-induced type II mixed cryoglobulinemia (MCII)	82
Operational considerations and challenges of biochemistry laboratories during the COVID-19 outbreak: An IFCC global survey	82
A new case of Echovirus 11 neonatal fulminant hepatitis involving male twins in a Northern Italy Tertiary University Hospital: Insight on a possible immunological clue	79
Chimeric antigen receptor (CAR)-redirected T cells: is there a place for them in infectious diseases?	79
Risks of "blind" automated identification systems in medical microbiology	79
Characterization of two human monoclonal anti-E2/HCV antibodies for potential application in prevention and treatment of HCV infection	79
Enteric microbiome markers as early predictors of clinical outcome in allogeneic hematopoietic stem cell transplant (allo-HSCT): results of a prospective study in adult patients	79
Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: Epitope definition and implications in risk stratification of patients under natalizumab therapy	78
Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects	78
SARS-CoV-2 infection despite high levels of vaccine-induced anti-Receptor-Binding-Domain antibodies: a study on 1110 health-care professionals from a northern Italian university hospital	78
Characterization of four major human B-cell epitopes on the surface of HCV E2 glycoprotein by generation of human monoclonal Fab from phage display antibody librariesis	78
Totale	12.014

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	92.628
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	92.628

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	145	0	0	0	17	4	0	35	21	16	21	11	20
2022/2023	704	19	7	13	34	34	52	0	39	267	129	35	75
2023/2024	2.699	371	395	336	500	572	254	23	55	79	66	12	36
2024/2025	3.254	24	58	629	141	102	159	134	134	353	184	465	871
2025/2026	8.073	594	409	616	987	541	292	1.857	436	961	550	455	375
2026/2027	2.784	689	449	884	762	0	0	0	0	0	0	0	0
Totale													18.429